Dokument Fact Sheet
Spezifizierung Immunthrombozytopenie (ITP) » rezidiviert/refraktär
Stand November 2020
Dies ist die aktuell gültige Version des Dokuments

1Fostamatinib, ITP, relapsed/refractory

1 N - number of patients7 SAE - serious adverse events, CTCAE grade 3/411 SR - sustained response12 OR - overall response14 results for control, results for new therapy15 hazard ratio for new therapy16 n. s. not significant19 platelets ≥50x109/L on 4 of 6 visits between week 14 and 2420 platelets ≥50x109/L within 12 weeks